New Alzheimer’s Treatment Targets cPLA2 Enzyme
USC scientists identified compounds that target cPLA2, an enzyme linked to Alzheimer's inflammation, especially in APOE4 gene carriers. This offers a potential new therapeutic approach for the disease.
Sox9 Boosts Astrocytes to Clear Alzheimer’s Plaques & Preserve Brain Function
Researchers discovered that boosting Sox9 expression empowers astrocytes to vacuum up amyloid plaques in Alzheimer's mouse models, preserving memory. This novel approach focuses on enhancing the brain's natural plaque-clearing mechanism, offering a potential new treatment strategy for neurodegenerative diseases.
Alzheimer’s Blood Test: Predicting Symptom Onset with p-tau217
A new blood test measuring p-tau217 protein can roughly predict Alzheimer's symptom onset, rising consistently before memory loss. Promising for early treatment, current models have limitations regarding range and participant diversity. Future research aims to improve accuracy.
Cognitive Speed Training Curbs Dementia Risk for 20 Years in Older Adults
A 20-year NIH-funded randomized trial found "speed of processing" cognitive training significantly reduced dementia risk by 25% in older adults, including Alzheimer's, making it the only intervention to show such long-term protective effects.
Low-Dose THC & Anti-Inflammatory: New Hope for Alzheimer’s Memory
New research suggests low-dose THC combined with an anti-inflammatory medicine could protect memory and reduce mental retardation in Alzheimer's, a disease affecting millions and previously resistant to COX-2 preventions, offering a faster potential therapy.
Alzheimer’s: Nanotubes Shuttle Toxins in Brain Cells
Johns Hopkins researchers discovered nanotubes in brain cells that transport toxins, including amyloid-beta related to Alzheimer's. Controlling these nanotubes could offer a future treatment.
Microplastics, APOE4 Gene, and Alzheimer’s: Cognitive Decline Risk
Research links microplastic exposure to cognitive decline and Alzheimer's, especially in those with the APOE4 gene. Sex-dependent behavior changes observed in mice mirror human Alzheimer's patients.
Alzheimer’s Research: Therapies, Challenges & Future
Alzheimer's research is at a critical point with initial therapies emerging, but more efficient drugs are needed. Research focuses on early treatments, inflammation's role, and overcoming funding challenges. Biomarkers are vital.
Alzheimer’s: Cancer Drugs Show Promise in Reversing Brain Changes
Researchers identify cancer drugs (Letrozole, Irinotecan) that may reverse Alzheimer's brain changes by targeting gene expression. Combination therapy shows promise in mouse model, paving way for clinical trials.
Alzheimer’s: Insulin Resistance Flags Rapid Cognitive Decline
High insulin resistance (TyG index) may flag early Alzheimer's patients at 4x greater risk of rapid cognitive decline, offering new treatment possibilities. Metabolic stress is key.